Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Hepatitis

  Free Subscription


Articles published in Blood

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    April 2020
  1. CAO W, Wei J, Wang N, Xu H, et al
    Entecavir Prophylaxis for Hepatitis B Virus Reactivation in Patients with CAR T-cell Therapy.
    Blood. 2020 Apr 14. pii: 454385. doi: 10.1182/blood.2020004907.
    PubMed    


    May 2019
  2. STRATI P, Nastoupil LJ, Fayad LE, Samaniego F, et al
    Safety of CAR T-Cell Therapy in Patients with B-Cell Lymphoma and Chronic Hepatitis B or C Virus Infection.
    Blood. 2019 May 17. pii: blood.2019000888. doi: 10.1182/blood.2019000888.
    PubMed    


    February 2019

  3. Ren W, Ye X, Su H, et al. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood. 2018;131(24):2670-2681.
    Blood. 2019;133:620.
    PubMed    


    December 2018
  4. PICARDI M, Della Pepa R, Giordano C, Zacheo I, et al
    Tenofovir versus lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.
    Blood. 2018 Dec 7. pii: blood-2018-10-878892. doi: 10.1182/blood-2018-10-878892.
    PubMed    


    October 2018
  5. KUSUMOTO S, Arcaini L, Hong X, Jin J, et al
    Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
    Blood. 2018 Oct 19. pii: blood-2018-04-848044. doi: 10.1182/blood-2018-04-848044
    PubMed     Abstract available


    March 2018
  6. REN W, Ye X, Su H, Li W, et al
    Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.
    Blood. 2018 Mar 15. pii: blood-2017-11-817601. doi: 10.1182/blood-2017-11-817601
    PubMed     Abstract available


    February 2018
  7. HAMMOND SP, Chen K, Pandit A, Davids MS, et al
    Risk of hepatitis B virus reactivation in patients treated with ibrutinib.
    Blood. 2018 Feb 28. pii: blood-2018-01-826495. doi: 10.1182/blood-2018-01-826495
    PubMed    


    December 2017
  8. TUCCI FA, Kitanovski S, Johansson P, Klein-Hitpass L, et al
    Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus-infected individuals.
    Blood. 2017 Dec 14. pii: blood-2017-09-805762. doi: 10.1182/blood-2017-09-805762
    PubMed     Abstract available


    August 2017
  9. NAM AS, Tam W
    An intrasinusoidal extracavitary variant of primary effusion lymphoma.
    Blood. 2017;130:836.
    PubMed    


    July 2017
  10. WAGNER-BALLON O, Michel M
    A rare case of autoimmune hemolytic anemia.
    Blood. 2017;130:559.
    PubMed    


    May 2017
  11. DEL PADRE M, Todi L, Mitrevski M, Marrapodi R, et al
    Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia.
    Blood. 2017 May 15. pii: blood-2017-03-771238. doi: 10.1182/blood-2017-03-771238
    PubMed     Abstract available


    January 2017
  12. MUCHTAR E, Magen H, Gertz MA
    How I treat cryoglobulinemia.
    Blood. 2017;129:289-298.
    PubMed     Abstract available


    May 2016
  13. LAMPSON BL, Kasar SN, Matos TR, Morgan EA, et al
    Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.
    Blood. 2016 May 31. pii: blood-2016-03-707133.
    PubMed     Abstract available


    March 2016
  14. ARCAINI L, Rossi D, Paulli M
    Splenic marginal zone lymphoma: from genetics to management.
    Blood. 2016 Mar 17. pii: blood-2015-11-624312.
    PubMed     Abstract available


  15. ZUCCA E, Bertoni F
    The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.
    Blood. 2016 Mar 17. pii: blood-2015-12-624304.
    PubMed     Abstract available


  16. THIEBLEMONT C, Molina T, Davi F
    Optimizing therapy for nodal marginal zone lymphoma.
    Blood. 2016 Mar 17. pii: blood-2015-12-624296.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: